Temple Study: CRISPR Removes HIV-Like Virus in Primate Models

Published on Temple University News (August 28, 2024)

In a major preclinical breakthrough, researchers at Temple University and Excision BioTherapeutics have successfully used a CRISPR-based therapy to eliminate the SIV virus, a close relative of HIV, from non-human primates. A single intravenous dose removed viral DNA from multiple tissues without adverse effects, showing promise for a potential functional cure. The approach is now advancing into human clinical trials.

Read the full article on Temple Medicine:

👉 Novel Treatment Based on Gene Editing Safely, Effectively Removes HIV Virus Genomes in Non-Human Primates

Images used are for illustrative purposes only and do not depict actual persons, products, or facilities. For full details, please refer to the original article via the provided link.